Andrew Last

Track

Insider profile

Currently holds positions in Affymetrix Inc and Bio-Rad Laboratories, Inc.

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 2% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Operating Officer, Executive Vice President Affymetrix Inc Jan. 9, 2014 -
Chief Operating Officer, Executive Vice President Bio-Rad Laboratories, Inc. April 22, 2019 -
Executive Vice President - Genetic Analysis Business Unit Affymetrix Inc Jan. 1, 2012 - Jan. 9, 2014
Executive Vice President, Chief Commercial Officer Affymetrix Inc Dec. 1, 2009 - Jan. 1, 2012
Andrew Last's trades of Bio-Rad Laboratories, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
31.22
Quantity 55,426
Value US$4,950,379
Transaction date
Proposed sale
Price
229.98
Quantity 51,499
Value US$4,767,805
Transaction date
Sale
Price
258.89
Quantity 29,898 -48.4%
Value US$2,108,162
Transaction date
Proposed sale
Price
329.94
Quantity 3,000
Value US$989,815
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-06 2024-11-06
PrS Proposed sale
55,426
31.22
US$4,950,379 		55,426 31.22 US$4,950,379
2024-09-12 2024-09-12
PrS Proposed sale
51,499
229.98
US$4,767,805 		51,499 229.98 US$4,767,805
2024-09-10 2024-09-06
S Sale
29,898 -48.4%
258.89
US$2,108,162 		29,898 -48.4% 258.89 US$2,108,162
2024-09-06 2024-09-06
PrS Proposed sale
3,000
329.94
US$989,815 		3,000 329.94 US$989,815
2022-08-19 2022-08-17
B Purchase
20,000 +39.9%
0.87
US$17,400 		20,000 +39.9% 0.87 US$17,400